ICD-10 Coding for Erythrocytosis(D75.0, D75.1, D75.1B)
Explore detailed ICD-10 coding guidelines for erythrocytosis, including primary and secondary codes, documentation requirements, and clinical validation.
Complete code families applicable to Erythrocytosis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D45 | Polycythemia vera | Use when JAK2 mutation is positive and bone marrow biopsy confirms PV. |
|
| D75.1 | Secondary polycythemia | Use when erythrocytosis is due to an underlying condition with elevated EPO. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutErythrocytosis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Erythrocytosis.
Failure to document EPO levels in secondary erythrocytosis.
Impact
Clinical: Misdiagnosis of erythrocytosis type., Regulatory: Non-compliance with coding standards., Financial: Potential for claim denials.
Mitigation
Ensure EPO levels are tested and documented., Link EPO results to the underlying condition.
Using D75.1 without linking to an underlying condition.
Impact
Reimbursement: Incorrect sequencing can lead to denied claims., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Always document and code the underlying condition first.
Incorrect sequencing of secondary erythrocytosis
Impact
Failure to sequence underlying condition first.
Mitigation
Educate coding staff on sequencing rules.